small molecule

CLONIDINE

Loss of exclusivity—loss of exclusivity

CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand name	CLONIDINE
Active ingredient	CLONIDINE
Strength	EQ 0.09MG BASE/ML
Dosage form	SUSPENSION, EXTENDED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	December 2009
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.